Chemotherapy alone versus chemotherapy plus targeted therapy as adjuvant therapy for initially unresectable colorectal cancer liver metastases: a multicenter cohort study.

Gastroenterol Rep (Oxf) · 2025 · PMC12630130 · PMID 41282550

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

In the CT cohort, subgroup analysis indicated a favorable trend of DFS for patients with KRAS / NRAS / BRAF mutations and receiving up to four cycles of conversion therapy ( P _interaction, 0.005 and 0.013, respectively).

also in 1,053 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.